Core Cap Advisors, LLC Biotechnology

Core Cap Advisors, LLC

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade
ERAS Erasca, Inc.	$167M	$0 0.0% of portfolio	100	Q4 2024 New
GBIO Generation Bio Co.	$34.2M	$0 0.0% of portfolio	415	Q4 2024 New
HRTX Heron Therapeutics, Inc.	$293M	$0 0.0% of portfolio	177	Q4 2024 New
IBRX Immunity Bio, Inc.	$1.32B	$0 0.0% of portfolio	70	Q4 2024 New
JANX Janux Therapeutics, Inc.	$1.37B	$0 0.0% of portfolio	9	Q4 2024 New
JAZZ Jazz Pharmaceuticals PLC	$9B	$0 0.0% of portfolio	7	Q3 2024 Reduced 46.15%
KYMR Kymera Therapeutics, Inc.	$1.72B	$0 0.0% of portfolio	16	Q4 2024 New
MNKD Mannkind Corp	$1.37B	$0 0.0% of portfolio	63	Q3 2024 Reduced 98.76%
NUVL Nuvalent, Inc.	$3.22B	$0 0.0% of portfolio	2	Q4 2024 New
OCGN Ocugen, Inc.	$141M	$0 0.0% of portfolio	10	Q4 2024 New
OLMA Olema Pharmaceuticals, Inc.	$177M	$0 0.0% of portfolio	69	Q4 2024 New
PRTA Prothena Corp Public LTD CO	$742M	$0 0.0% of portfolio	23	Q2 2024 New
SANA Sana Biotechnology, Inc.	$497M	$0 0.0% of portfolio	278	Q4 2024 New
SRPT Sarepta Therapeutics, Inc.	$9.35B	$0 0.0% of portfolio	7	Q4 2024 New
SPRO Spero Therapeutics, Inc.	$27.4M	$0 0.0% of portfolio	50	Q4 2024 Reduced 73.96%
TSHA Taysha Gene Therapies, Inc.	$77.4M	$0 0.0% of portfolio	380	Q4 2024 New
TYRA Tyra Biosciences, Inc.	$492M	$0 0.0% of portfolio	16	Q4 2024 New
PCVX Vaxcyte, Inc.	$4.33B	$0 0.0% of portfolio	8	Q4 2024 New

Get notified when there are updates to the investment portfolio of Core Cap Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Core Cap Advisors, LLC with notifications on news.